AMGEN Inc. Live Share Price Today, Share Analysis and Chart
about
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...
Read More275.84 5.40 (2.00%)
2.3M XNAS Volume
XNAS 07 May, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Bearish
Expensive Underperformer
These stocks are medium in financial scores. They have bad valuation and technical scores as well.
View Similar
Embed DVM
AMGEN Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..